Peptide-Induced Antigen-Specific CD4+CD25+FoxP3+ T Cells Suppress Cytotoxicity T Cell Responses Directed Against the AAV Capsid.
Daniel J. Hui(Children's Hospital of Philadelphia), Federico Mingozzi(Spark Therapeutics (United States)), William Martin(Emory University), Katherine A. High(Spark Therapeutics (United States)), Etiena Basner‐Tschakarjan(Children's Hospital of Philadelphia), Gary C. Pien(Children's Hospital of Philadelphia)
Cited by 2
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Gene therapy comes of age
|Science|2018|1.4k
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|864